Date:11/9/2009

ies will capitalize on the outstanding business environment, infrastructure and healthcare resources that propelled our growth in the last several years," says Bill Elliott, Access MediQuip President and COO. "In addition to its pro-business climate, the Lake Mary area offers a talent pool with deep experience in specialty managed care that will facilitate our ability to attract the quality human resources we will need to achieve our vision."

Access MediQuip is the nation's first and largest provider of outsourced implantable medical device management solutions. The company works with thousands of payers, manufacturers and providers to manage the acquisition, financing, delivery and reimbursement of implantable medical devices such as orthopedic and spinal implants. Founded in 1997, the company is now headquartered in Lake Mary, Florida. For more information, please visit www.accessmediquip.com.

SOURCE Access MediQuip, LLC

'/>"/>

SOURCE Access MediQuip, LLC Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine technology :

1. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
2. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
3. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
4. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
5. Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
6. Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
7. Demand for Spanish-Language Cancer Web Materials Quadruples; Internet Resources and Access Remain Scarce
8. New Analysis from 14 Countries Identifies Drug Access Priorities to Achieve 2010 AIDS Treatment Target
9. Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
10. Childrens Hospital Cancer Study Finds Adolescents and Young Adults Dont Get Same Access to Cutting-Edge Treatment as Younger Patients
11. Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis